Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Delaware Chancery Court Vice Chancellor Myron Steele cleared the way last week for Medco Research Inc.’s shareholders to approve King Pharmaceuticals Inc.’s $342 million takeover offer for the maker of heart drugs.

Steele on Feb. 24 rebuffed a bid by the State of Wisconsin Investment Board to block the vote on the stock-for-stock offer, valued at $32.65 per share. Medco shareholders approved the offer on Feb. 25 with 5.75 million shares in favor of the merger and 2.9 million shares against.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.